George Migausky V.
Chief Financial Officer, BIOVERIS CORP.
Companies
- REGENXBIO Inc.Board member Sep 8, 2021 to now1
- Immunovant, Inc.Board member May 9, 2019 to now2
- ABEONA THERAPEUTICS INC.Board member Jun 19, 2020 to Jun 19, 20203
- OCULAR THERAPEUTIX, INCChief financial officer Apr 12, 2017 to Apr 12, 20174
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Immunovant, Inc. IMVT137,251 shares5$3.8M at $27.45Apr 1, 2025
- REGENXBIO Inc. RGNX28,861 shares6$208.2K at $7.21May 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 29, 2026Granted 9,807 shares of REGENXBIO Inc.6
- May 30, 2025Granted 7,768 shares of REGENXBIO Inc.7
- Apr 1, 2025Granted 16,188 shares of Immunovant, Inc.5
- May 31, 2024Granted 4,790 shares of REGENXBIO Inc.8
- Apr 2, 2024Granted 11,255 shares of Immunovant, Inc.9
- Dec 1, 2023Sold 5,022 shares at $40.46 of Immunovant, Inc.10
- Dec 1, 2023Sold 3,478 shares at $39.81 of Immunovant, Inc.10
- Dec 1, 2023Sold 4,200 shares at $38.79 of Immunovant, Inc.10
- Jun 2, 2023Granted 3,486 shares of REGENXBIO Inc.11
- Apr 12, 2023Granted 12,523 shares of Immunovant, Inc.12
- Aug 17, 2022Granted 21,059 shares of Immunovant, Inc.13
- Jun 3, 2022Granted 3,010 shares of REGENXBIO Inc.14
- Jan 10, 2022Granted 21,726 shares of Immunovant, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARREGENXBIO Inc., Board member
- 2SEC EDGARImmunovant, Inc., Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 3, 2025
- 8SEC EDGARForm 4 filed Jun 4, 2024
- 9SEC EDGARForm 4 filed Apr 4, 2024
- 10SEC EDGARForm 4 filed Dec 5, 2023
- 11SEC EDGARForm 4 filed Jun 6, 2023
- 12SEC EDGARForm 4 filed Apr 14, 2023
- 13SEC EDGARForm 4 filed Aug 19, 2022
- 14SEC EDGARForm 4 filed Jun 7, 2022
- 15SEC EDGARForm 4 filed Jan 12, 2022